ATE543906T1 - Antigen von streptococcus aus der b-gruppe - Google Patents

Antigen von streptococcus aus der b-gruppe

Info

Publication number
ATE543906T1
ATE543906T1 AT03701402T AT03701402T ATE543906T1 AT E543906 T1 ATE543906 T1 AT E543906T1 AT 03701402 T AT03701402 T AT 03701402T AT 03701402 T AT03701402 T AT 03701402T AT E543906 T1 ATE543906 T1 AT E543906T1
Authority
AT
Austria
Prior art keywords
streptococcus
group
antigen
epitopes
gbs
Prior art date
Application number
AT03701402T
Other languages
English (en)
Inventor
Stephane Rioux
Denis Martin
Josee Hamel
Bernard Brodeur
Original Assignee
Id Biomedical Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Id Biomedical Corp filed Critical Id Biomedical Corp
Application granted granted Critical
Publication of ATE543906T1 publication Critical patent/ATE543906T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Rheumatology (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Dermatology (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Oncology (AREA)
  • Cardiology (AREA)
  • Pulmonology (AREA)
  • Communicable Diseases (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AT03701402T 2002-02-11 2003-02-11 Antigen von streptococcus aus der b-gruppe ATE543906T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US35494702P 2002-02-11 2002-02-11
PCT/CA2003/000186 WO2003068813A2 (en) 2002-02-11 2003-02-11 Group b streptococcus antigen

Publications (1)

Publication Number Publication Date
ATE543906T1 true ATE543906T1 (de) 2012-02-15

Family

ID=27734441

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03701402T ATE543906T1 (de) 2002-02-11 2003-02-11 Antigen von streptococcus aus der b-gruppe

Country Status (8)

Country Link
US (1) US20070275004A1 (de)
EP (1) EP1472353B1 (de)
JP (1) JP2005535287A (de)
AT (1) ATE543906T1 (de)
AU (1) AU2003203097C1 (de)
CA (1) CA2475821C (de)
ES (1) ES2381967T3 (de)
WO (1) WO2003068813A2 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TR200002437T2 (tr) * 1998-02-20 2000-11-21 Biochem Pharma Inc. B grubu streptococcus antijenleri.
ATE439372T1 (de) 2000-10-27 2009-08-15 Novartis Vaccines & Diagnostic Nukleinsäuren und proteine von gruppen a und b- streptokokken
JP4875490B2 (ja) 2003-07-31 2012-02-15 ノバルティス バクシンズ アンド ダイアグノスティックス，インコーポレーテッド ＳｔｒｅｐｔｏｃｏｃｃｕｓＰｙｏｇｅｎｅｓについての免疫原組成物
US8945589B2 (en) 2003-09-15 2015-02-03 Novartis Vaccines And Diagnostics, Srl Immunogenic compositions for Streptococcus agalactiae
US20060165716A1 (en) 2004-07-29 2006-07-27 Telford John L Immunogenic compositions for gram positive bacteria such as streptococcus agalactiae
WO2006086330A2 (en) * 2005-02-08 2006-08-17 Id Biomedical Corporation Of Quebec C.O.B. As Glaxosmithkline Biologicals North America Pharmaceutical compositions
ES2310062B1 (es) * 2005-07-15 2009-11-13 Bionostra, S.L. Particulas pseudovirales vacias quimericas derivadas del virus causante de la enfermedad de la bursitis infecciosa (ibdv), procedimiento de obtencion y aplicaciones.
CA2699513C (en) 2007-09-12 2018-03-13 Novartis Ag Gas57 mutant antigens and gas57 antibodies
CN103834669B (zh) * 2014-02-21 2016-06-29 通威股份有限公司 一种无乳链球菌的口服疫苗及其制备方法
CN107502622A (zh) * 2016-06-14 2017-12-22 广东省农业科学院动物卫生研究所 Sip基因重组载体、壳聚糖‑PLGA包裹Sip基因DNA疫苗及其制备方法和应用
CA3103442A1 (en) 2018-06-13 2019-12-19 Gen-Probe Incorporated Compositions and methods for detecting group b streptococcus nucleic acid

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5302386A (en) * 1986-04-16 1994-04-12 Brigham And Women's Hospital, Inc. Bacterial antigens, antibodies, vaccines and methods of manufacture
US5472696A (en) * 1988-02-26 1995-12-05 Univ. Of Florida Research Foundation, Inc. Antigen of group B streptococci
US5648241A (en) * 1989-09-15 1997-07-15 The General Hospital Corporation Conjugate vaccine against group B streptococcus
US5679768A (en) * 1991-02-15 1997-10-21 Uab Research Foundation Epitopic regions of pneumococcal surface protein A
US5225331A (en) * 1991-04-25 1993-07-06 National Research Council Of Canada Immunoassay for detecting group b streptococcus
PT656014E (pt) * 1993-03-19 2003-09-30 Gunnar Lindahl Proteina rib, uma proteina da superficie celular que confere imunidade a muitas estirpes de estreptococos do grupo b: processo para purificacao da proteina, estojo de reagentes e composicao farmaceutica
US5595740A (en) * 1994-05-16 1997-01-21 University Of Florida Cloning of non-IgA FC binding forms of the group B streptococcal beta antigens
US5843713A (en) * 1994-11-01 1998-12-01 Kirin Beer Kabushiki Kaisha Peptide sequence that forms mucin sugar chain and technique for modifying protein to be linked with mucin sugar chain
TR200002437T2 (tr) * 1998-02-20 2000-11-21 Biochem Pharma Inc. B grubu streptococcus antijenleri.
GB9921125D0 (en) * 1999-09-07 1999-11-10 Microbial Technics Limited Proteins

Also Published As

Publication number Publication date
JP2005535287A (ja) 2005-11-24
CA2475821C (en) 2011-12-13
CA2475821A1 (en) 2003-08-21
AU2003203097C1 (en) 2010-02-04
EP1472353A2 (de) 2004-11-03
WO2003068813A3 (en) 2003-10-16
US20070275004A1 (en) 2007-11-29
WO2003068813A2 (en) 2003-08-21
AU2003203097A1 (en) 2003-09-04
ES2381967T3 (es) 2012-06-04
AU2003203097B2 (en) 2009-10-01
EP1472353B1 (de) 2012-02-01

Similar Documents

Publication Publication Date Title
NO20063026L (no) Antistoffer
GEP20115333B (en) Antagonist antibodies directed against calcitonin generelated peptide and using same
MA40801A1 (fr) Anticorps anti-cd3, anticorps anti-cd123 et anticorps bispécifiques se liant spécifiquement à cd3 et/ou cd123
IL195338A (en) An antibody comprising an FC variant containing amino acid replaces d or e at position 239, a medicament containing it and its use
MX338940B (es) Identificacion de epitopos ige novedosos.
DK1362109T3 (da) Rekombinante oligomere protein-komplekser med foröget immunogent potentiale
BG104149A (bg) Белтъци, свързващи интерлевкин-18, тяхното получаване и приложение
BRPI0506771A (pt) anticorpo, e, composição farmacêutica
NO20041917D0 (no) Spesifikke midler som binder humant angiopoietin-2
UA89017C2 (uk) ЛЮДСЬКЕ АНТИТІЛО, ЩО СПЕЦИФІЧНО ЗВ'ЯЗУЄТЬСЯ З ЛЮДСЬКИМ TNFSF13b
ATE387629T1 (de) Gemeinsame epitope von antigenen aus einer multigen-familie
CR20220660A (es) Métodos para tratar o prevenir infecciones por sars-cov2 y covid-19 con anticuerpos de glicoproteína espícular anti-sars-cov-2
ATE356206T1 (de) Menschliches krebsantigen ny eso-1/cag-3 und dazu kodierendes gen
ATE363531T1 (de) Claudin polypeptide
WO2003068813A3 (en) Group b streptococcus antigen
ATE537186T1 (de) P53-bindendes polypeptid
ATE477274T1 (de) Gegen clostridium difficile gerichtete antikörper
ATE453714T1 (de) Antigene aus cryptosporidium parvum, antikörper dagegen und diagnostische und therapeutische zusammensetzungen
EA200702193A1 (ru) Гликозилирование белков
BR0113099A (pt) Gene e proteìna relacionados com esquizofrenia
DK1368372T3 (da) Peptid med affinitet til det virale gp120-protein samt anvendelse deraf
WO2006086330A3 (en) Pharmaceutical compositions
ATE230761T1 (de) Monoklonale antikörper gegen einen komplex aus humanem act und einer serinprotease
DE60234772D1 (de) Gruppe-b streptococcus antigene und entsprechende dna-fragmente
WO2002090542A8 (en) Antigenic epitopes of factor viii, inhibitors directed against said epitopes and use thereof